The Butrans patch is a prescription skin patch that delivers a steady dose of buprenorphine, an opioid pain reliever, through the skin over seven days. It’s designed for people with severe, persistent pain who need continuous, around-the-clock opioid treatment and haven’t gotten adequate relief from other options, including shorter-acting opioid pills.
Unlike pain medications you take by mouth several times a day, the Butrans patch releases medication slowly and continuously. This provides more stable pain control without the peaks and valleys that come with swallowing a pill every few hours.
How the Butrans Patch Works
Buprenorphine, the active drug in the patch, is classified as a partial opioid agonist. That distinction matters. A full opioid agonist (like morphine or oxycodone) activates pain-blocking receptors in the brain and spinal cord at full strength. Buprenorphine activates those same receptors, but only partially. The result is meaningful pain relief and some sedation, but with a built-in ceiling effect: after a certain point, taking more doesn’t increase the effect the way a full opioid would.
This partial activation is one reason buprenorphine carries a somewhat lower risk of the most dangerous opioid side effect, slowed breathing, compared to full opioid agonists. That said, it is still an opioid, still carries risks of dependence and misuse, and is classified as a Schedule III controlled substance.
Who It’s Prescribed For
The FDA approved Butrans specifically for severe and persistent pain that requires daily opioid treatment over an extended period, when other pain medicines (including immediate-release opioids) haven’t worked well enough or can’t be tolerated. It is not meant for occasional or as-needed pain relief. If your pain comes and goes or responds to over-the-counter painkillers, this patch isn’t the right fit.
Common conditions where Butrans might be considered include chronic low back pain, osteoarthritis pain that hasn’t responded to other treatments, and neuropathic pain syndromes. It’s typically reserved for situations where a prescriber has already tried non-opioid approaches and shorter-acting medications.
Available Strengths and Wear Schedule
Butrans patches come in five strengths: 5, 7.5, 10, 15, and 20 micrograms per hour. Each patch is worn for a full seven days before being replaced. People who haven’t taken opioids before typically start at the lowest strength, and the dose is adjusted gradually based on how well the pain is controlled and how the body responds.
Because the medication absorbs through the skin and builds up in the body over time, it can take several days after applying the first patch to reach full, steady pain levels in the bloodstream. Your prescriber may provide a short-acting pain reliever to bridge that gap during the first week.
Where and How to Apply the Patch
The patch is applied to a flat area of skin on the upper outer arm, upper chest, upper back, or the side of the chest. The skin should be clean, dry, and free of cuts, irritation, or hair (if you need to remove hair, clip it rather than shaving, which can irritate the skin). Press the patch firmly in place with the palm of your hand for about 15 seconds to ensure good contact.
Each time you apply a new patch, use a different spot. You should wait at least 21 days before reusing the same area of skin. This rotation prevents the skin irritation that can develop from repeated application to one location. Avoid placing the patch anywhere that a belt, waistband, or tight clothing could rub against it.
Heat Exposure Is a Real Risk
One of the most important practical warnings with any transdermal patch is heat. Applying a heating pad over or near the patch, soaking in a hot tub, using a sauna, or even running a high fever can increase how quickly the drug absorbs through the skin. That means you could get a larger dose than intended, raising the risk of serious side effects including dangerously slowed breathing. If you use a Butrans patch, keep the application site away from direct heat sources.
Common Side Effects
The most frequently reported side effects are ones common to opioids in general: nausea, constipation, headache, dizziness, drowsiness, and vomiting. Skin reactions at the application site are also common, including redness, itching, and rash. Rotating application sites helps reduce this, but some degree of local irritation is expected for many people.
More serious risks include slowed or shallow breathing (especially in the first 24 to 72 hours or after a dose increase), severe drops in blood pressure when standing up, and changes in heart rhythm. Combining the patch with alcohol, benzodiazepines (like Valium or Xanax), or other sedating substances significantly raises the risk of life-threatening breathing problems.
Long-term use can lead to physical dependence, meaning your body adapts to the drug and you’ll experience withdrawal symptoms if the patch is suddenly removed. Stopping Butrans is done gradually, with your prescriber tapering the dose over time to minimize withdrawal.
Safe Disposal
Even after seven days of wear, a used Butrans patch still contains enough buprenorphine to be dangerous, especially to children or pets. The FDA includes Butrans on its “flush list,” a short list of medications considered so risky from accidental exposure that flushing them down the toilet is the recommended disposal method if you don’t have access to a drug take-back program. Fold the used patch in half so the sticky sides press together, then flush it immediately. Unused patches should be handled the same way: remove from the pouch, peel off the liner, fold sticky sides together, and flush.
Drug take-back programs at pharmacies or community collection events are the preferred option when available. But if neither a take-back location nor a mail-back envelope is accessible to you, flushing is safer than leaving a used patch in the household trash where someone could encounter it.
How Butrans Compares to Other Opioid Patches
The most well-known opioid patch is fentanyl (Duragesic), which is a full opioid agonist and significantly more potent. Butrans delivers buprenorphine at much lower equivalent doses and is generally considered appropriate for moderate-to-severe chronic pain, while fentanyl patches are reserved for opioid-tolerant patients with more intense pain. The partial agonist nature of buprenorphine gives Butrans a somewhat wider safety margin regarding respiratory depression, though it is not risk-free.
For people already taking high doses of other opioids, the maximum Butrans strength (20 mcg/hour) may not provide enough relief. The patch is best suited for patients whose pain requires continuous opioid therapy but at lower overall opioid doses.